Global pharmaceutical giant Bayer will spend up to $US10.9 billion ($15.87b) to settle thousands of lawsuits alleging the company’s weedkiller, Roundup, causes cancer.
Key points:
- Bayer will settle almost 100,000 lawsuits brought largely by claimants who say the weedkiller Roundup causes cancer
- The company will also settle other claims relating to environmental damage in the US
- The US Environmental Protection Agency found the active ingredient in Roundup was “unlikely to be a human carcinogen”
The Germany-based company, which bought Roundup maker Monsan